Indian pharmacy in global context and market survey of antioxidant, ofloxacin, cefixin and cefuroxime
Summary :
Table of Contents
- Introduction
- The Indian pharmaceutical sector
- Advantages in India
- The growth scenario
- Steps to strengthen the industry
- Future prospects of the pharmaceutical industry in India
- Research and development in the pharmaceutical industry
- A study on Wockhardt
- Mission and business philosophy
- Wockhardt and international pharma
- Marketing division
- Tie ups with Wallis laboratory limited and CP pharmaceuticals limited - UK
- Overview of the research and development
- Financial overview of Wockhardt
- Research methodology and survey
- Conclusion
- Bibliography
Abstract
The indian Pharmaceutical Industry today is in the front rank of India's science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organized sector, the indian pharmacy Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.
Playing a key role in promoting and sustaining development in the vital field of medicines, indian pharmacy Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world.
The indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control.
Playing a key role in promoting and sustaining development in the vital field of medicines, indian pharmacy Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world.
The indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control.
Latest in the category : Business strategy
5
Determination of hire charges on mobile equipment of MSG (mechanical) for external business at Tata steel
Research papers | 10/29/2009 | en | .doc | 45 pages
Most downloaded in the last 30 days : Business strategy
From the same author : Business strategy
1
Promotion of world calling card, sales and brand image of Vodafone
Research papers | 05/28/2009 | en | .doc | 38 pages
2
Working capital management in Hindalco (Aditya Birla Group)
Research papers | 05/28/2009 | en | .doc | 60 pages
4
A comparative study of services and prices between public and private sector broadband providers
Research papers | 05/28/2009 | en | .doc | 33 pages
Change Currency
Our guarantee :
How it works?
Quality guaranteed
Refunds
Secure payment
Who are we ?
